Orthocell develops, manufactures and exports novel regenerative medicine products around the world.
Its biological medical devices and cellular therapies are used by leading surgeons to treat musculoskeletal injuries of nerve, tendon and cartilage, and dental bone defects. The clinical results, compelling.
Our founding story
Orthocell’s origins lay in a purposeful meeting of bright, solutions-focused minds more than 15 years ago, who saw the potential for biological solutions to repair the human body, in applications traditionally dominated by materials like metal and plastic.
One of those leaders was Orthocell’s Co-Founder and Managing Director, Paul Anderson, a former orthopedic nurse who moved swiftly into the commercial side of medicine to work in product sales and ultimately, as a successful entrepreneur, working alongside respected academic visionaries in the orthopedics space.
Through his association with The University of Western Australia, Paul started collaborating with Orthocell’s now Co-Founder and Chief Scientific Officer, Professor Ming Hao Zheng, to develop technologies to produce novel regenerative medicine treatments.
Theirs is a strong and proven partnership. Paul and Professor Zheng have previously commercialized cartilage repair technology together – and sold it to an American company – which had a current market capitalization of more than US $1B. Key learnings from this chapter challenged them to pursue the next ‘big thing’ in regenerative medicine.
With two promising products in the pipeline, they secured venture capital funding from a Western Australian-based VC firm to build the laboratory and fund the clinical trial programs; together with non-diluted funding from the State government. Orthocell was listed on the Australian Securities Exchange (ASX) in 2014.
Commitment to Clinical Excellence
The clinical utility of every Orthocell product is underpinned by the Company’s mission to improve mobility, function and quality of life – without exception. Orthocell’s success stems from a deep understanding of tissue engineering principles, and in particular the interaction between cells and scaffolds, which can promote healthy repair of nerve, tendon, cartilage and dental bone defects.
Orthocell products enhance the body’s natural ability to heal. More than 70,000 patients have been treated to date, with no adverse events reported. These products are carefully designed to assist surgeons – in particular, orthopedic, plastic, reconstructive, and dental surgeons – to simplify procedures, save operative time and deliver consistent and predictable outcomes for their patients.
Orthocell works with leading surgeons and centers of excellence to translate research into novel products that improve the standard of care for patients with a variety of musculoskeletal injuries. The Orthocell team is committed to expanding its suite of medical devices and is exploring new applications for both existing and future products.
World-Class Manufacturing Facility
Orthocell has established a quality-controlled facility at its headquarters in Perth, Western Australia. The facility is licensed by the Therapeutic Goods Administration (TGA) for the manufacture of human tendon cells (tenocytes) and cartilage cells (chondrocytes) for the regeneration of damaged tendon and cartilage. The facility is also certified to ISO 13485 for the manufacture of Remplir™ and Striate+™. Orthocell is equipped to manufacture, scale up and export products around the world.
Our Partners
“Whether caused by acute or chronic injury, musculoskeletal disorders can profoundly affect our overall well-being. At our core, Orthocell’s purpose is to improve the lives of individuals suffering from debilitating conditions by providing advanced, effective treatments that promote true healing and recovery. Our solutions are designed to enhance the body’s natural ability to repair, promote sustainable healing and restore function – and are garnering remarkable results in practice.”
Paul Anderson
Orthocell Co-Founder and Managing Director
Meet the Orthocell team
Meet the experts driving our regenerative breakthroughs and learn more about our commitment to medical excellence. Connect with the Orthocell team today to discover how we are redefining the future of patient care.
Meet the team